{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:03:27Z","timestamp":1790064207027,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1053\/j.semdp.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T07:14:47Z","timestamp":1520061287000},"page":"236-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types"],"prefix":"10.1053","volume":"35","author":[{"given":"Nadine","family":"Aguilera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2018.02.001_bib0001","unstructured":"Swerdlow S.H., Webber S.A., Chadburn A., Ferry J.A. Post-transplant lymphoproliferative disorders. 5th ed. Lyon, France: International Agency for Research on Cancer; 2017."},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0003","first-page":"102","article-title":"Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey","volume":"15","author":"Izadi","year":"2010","journal-title":"Ann Transplant"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"issue":"20","key":"10.1053\/j.semdp.2018.02.001_bib0005","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0006","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1309\/AJCPQYYE04AVGVYI","article-title":"Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation","volume":"138","author":"Nelson","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0007","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-5876(02)00356-7","article-title":"Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation","volume":"67","author":"Shapiro","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0008","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.humpath.2006.08.014","article-title":"Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion","volume":"38","author":"Vakiani","year":"2007","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0009","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0b013e3182190999","article-title":"EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder","volume":"35","author":"Gibson","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00000478-200001000-00012","article-title":"Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients","volume":"24","author":"Hsi","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0011","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajcp\/aqx134","article-title":"Epstein-Barr Virus-Positive Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue in the Posttransplant Setting: An Immunodeficiency-Related (Posttransplant) Lymphoproliferative Disorder","volume":"149","author":"Cassidy","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0012","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1111\/petr.12111","article-title":"EBV-positive low-grade marginal zone lymphoma in the breast with massive amyloid deposition arising in a heart transplant patient: A report of an unusual case","volume":"17","author":"Nassif","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0013","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","article-title":"T-cell and NK-cell posttransplantation lymphoproliferative disorders","volume":"127","author":"Swerdlow","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0014","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/TP.0b013e3182762e07","article-title":"Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases","volume":"95","author":"Tiede","year":"2013","journal-title":"Transplantation"},{"issue":"10","key":"10.1053\/j.semdp.2018.02.001_bib0015","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3109\/10428194.2013.775436","article-title":"Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases","volume":"54","author":"Herreman","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"46","key":"10.1053\/j.semdp.2018.02.001_bib0016","doi-asserted-by":"crossref","first-page":"81697","DOI":"10.18632\/oncotarget.21009","article-title":"Large granular lymphocytosis after transplantation","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1053\/j.semdp.2018.02.001_bib0017","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/bmt.2011.212","article-title":"Indolent T-cell large granular lymphocyte leukaemia after haematopoietic SCT: a clinicopathologic and molecular analysis","volume":"47","author":"Gill","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.semdp.2018.02.001_bib0018","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/j.transproceed.2006.10.045","article-title":"Clonal T-large granular lymphocyte proliferation in solid organ transplant recipients","volume":"38","author":"Sabnani","year":"2006","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0019","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bjh.13917","article-title":"Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations","volume":"172","author":"Munoz-Ballester","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2018.02.001_bib0020","first-page":"3","article-title":"Four hepatosplenic T-cell lymphoma cases of Japanese patients","volume":"5","author":"Kawai","year":"2016","journal-title":"Leuk Res Rep"},{"key":"10.1053\/j.semdp.2018.02.001_bib0021","unstructured":"Gaulard P., Swerdlow S.H., Harris N.L., Sundstrom C., Jaffe E.S. EBV-positive mucocutaneous ulcer. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017."},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0022","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.oooo.2015.06.028","article-title":"EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV\/AIDS","volume":"120","author":"Bunn","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"19","key":"10.1053\/j.semdp.2018.02.001_bib0023","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3748\/wjg.v21.i19.6072","article-title":"Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease","volume":"21","author":"Moran","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1053\/j.semdp.2018.02.001_bib0024","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ccr3.287","article-title":"Age-related Epstein-Barr virus-positive mucocutaneous ulcer: a case report","volume":"3","author":"Magalhaes","year":"2015","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2014.12.003","article-title":"Human papillomavirus and Epstein-Barr virus associated conditions of the oral mucosa","volume":"32","author":"Stojanov","year":"2015","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.path.2017.01.001","article-title":"Epstein-Barr Virus-associated Lymphoproliferative Disorders in the Skin","volume":"10","author":"Goodlad","year":"2017","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH\/EAHP Workshop Report-Part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0029","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2015.245","article-title":"Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer","volume":"51","author":"Nelson","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1053\/j.semdp.2018.02.001_bib0030","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0031","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0032","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1440-1827.2009.02466.x","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity","volume":"59","author":"Shimoyama","year":"2009","journal-title":"Pathology international"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0033","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0b013e3181fd8781","article-title":"Lymphomatoid granulomatosis: insights gained over 4 decades","volume":"34","author":"Katzenstein","year":"2010","journal-title":"The American Journal of Surgical Pathology"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0034","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid Granulomatosis-A Single Institute Experience: Pathologic Findings and Clinical Correlations","volume":"39","author":"Song","year":"2015","journal-title":"The American Journal of Surgical Pathology"},{"key":"10.1053\/j.semdp.2018.02.001_bib0035","unstructured":"Pittaluga S., Wilson W.H., Jaffe E.S. Lymphomatoid granulomatosis. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008."},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0036","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0046-8177(72)80005-4","article-title":"Lymphomatoid granulomatosis","volume":"3","author":"Liebow","year":"1972","journal-title":"Human Pathology"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0037","first-page":"401","article-title":"Cutaneous lymphoproliferative disorders in organ transplant recipients: update","volume":"149","author":"Seckin","year":"2014","journal-title":"Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0038","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09031936.98.12010102","article-title":"Lymphomatoid granulomatosis\u2013a report on four cases: evidence for B phenotype of the tumoral cells","volume":"12","author":"Taniere","year":"1998","journal-title":"The European Respiratory Journal"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2014.07.034","article-title":"Epstein-Barr virus: Dermatologic associations and implications: Part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders","volume":"72","author":"Hall","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archderm.1981.01650120050022","article-title":"Microvascular injury in lymphomatoid granulomatosis involving the skin. An ultrastructural study","volume":"117","author":"Murphy","year":"1981","journal-title":"Archives of dermatology"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0041","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000246751","article-title":"Adhesion molecules in lymphomatoid granulomatosis","volume":"189","author":"Savoia","year":"1994","journal-title":"Dermatology"},{"issue":"10","key":"10.1053\/j.semdp.2018.02.001_bib0042","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood.V90.10.4099","article-title":"The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease","volume":"90","author":"Teruya-Feldstein","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2018.02.001_bib0043","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"The American Journal of Surgical Pathology"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2014.07.035","article-title":"Epstein-Barr virus: Dermatologic associations and implications: Part II. Associated lymphoproliferative disorders and solid tumors","volume":"72","author":"Eminger","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/cup.12402","article-title":"Lymphomatoid granulomatosis presenting with cutaneous involvement: a case report and review of the literature","volume":"42","author":"Rysgaard","year":"2015","journal-title":"Journal of Cutaneous Pathology"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0046","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","article-title":"Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"The American Journal of Dermatopathology"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0047","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-4362.1994.tb04969.x","article-title":"Lymphomatoid granulomatosis","volume":"33","author":"Magro","year":"1994","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0048","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archderm.1975.01630160083009","article-title":"Lymphomatoid granulomatosis of the skin. A new clinocopathologic entity","volume":"111","author":"Minars","year":"1975","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0049","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcp\/106.1.69","article-title":"Angiocentric immunoproliferative lesions of the lymph node","volume":"106","author":"Takeshita","year":"1996","journal-title":"American Journal of Clinical Pathology"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0050","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaad.2005.11.1066","article-title":"Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient","volume":"54","author":"Kwon","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1053\/j.semdp.2018.02.001_bib0051","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1346-8138.2010.01186.x","article-title":"Cutaneous lesion of lymphomatoid granulomatosis in a Korean woman with secondary myelofibrosis","volume":"38","author":"Park","year":"2011","journal-title":"The Journal of Dermatology"},{"issue":"7","key":"10.1053\/j.semdp.2018.02.001_bib0052","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jcp.56.7.555","article-title":"Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy","volume":"56","author":"Sebire","year":"2003","journal-title":"Journal of Clinical Pathology"},{"issue":"5","key":"10.1053\/j.semdp.2018.02.001_bib0053","first-page":"488","article-title":"[Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation]","volume":"127","author":"Tas","year":"2000","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0054","first-page":"347","article-title":"Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection","volume":"11","author":"Haque","year":"1998","journal-title":"Modern Pathology: an official Journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"5","key":"10.1053\/j.semdp.2018.02.001_bib0055","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/ijd.13551","article-title":"Cutaneous human immunodeficiency virus (HIV)-associated lymphomatoid granulomatosis: complete regression following antiretroviral therapy","volume":"56","author":"Prieto Herman Reinehr","year":"2017","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0056","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases","volume":"43","author":"Katzenstein","year":"1979","journal-title":"Cancer"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0057","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archderm.1996.03890360054010","article-title":"Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder","volume":"132","author":"McNiff","year":"1996","journal-title":"Archives of Dermatology"},{"key":"10.1053\/j.semdp.2018.02.001_bib0058","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-230X-14-127","article-title":"Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease","volume":"14","author":"Connors","year":"2014","journal-title":"BMC Gastroenterology"},{"issue":"20","key":"10.1053\/j.semdp.2018.02.001_bib0059","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1200\/JCO.2012.46.2770","article-title":"Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis","volume":"31","author":"Ochi","year":"2013","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0060","first-page":"321","article-title":"[Methotrexate-related lymphomatoid granulomatosis successfully treated with discontinuation of methotrexate and radiotherapy to brain]","volume":"55","author":"Yamakawa","year":"2014","journal-title":"[Rinsho ketsueki] The Japanese journal of clinical hematology"},{"issue":"9","key":"10.1053\/j.semdp.2018.02.001_bib0061","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archderm.143.9.1222","article-title":"Lymphomatoid granulomatosis induced by imatinib-treatment","volume":"143","author":"Yazdi","year":"2007","journal-title":"Archives of dermatology"},{"key":"10.1053\/j.semdp.2018.02.001_bib0062","doi-asserted-by":"crossref","DOI":"10.1007\/s11748-017-0871-0","article-title":"A surgical case of methotrexate-associated lymphomatoid granuloma","author":"Watanabe","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0063","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAS.0000000000000954","article-title":"Cancer Therapy-associated Lymphoproliferative Disorders: An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder","volume":"42","author":"Pina-Oviedo","year":"2018","journal-title":"The American journal of surgical pathology"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0064","first-page":"119","article-title":"Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis","volume":"80","author":"Blanchart","year":"2014","journal-title":"Minerva Anestesiol"},{"issue":"7","key":"10.1053\/j.semdp.2018.02.001_bib0065","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/archderm.1978.01640190040014","article-title":"Lymphomatoid granulomatosis after immunosuppression for pemphigus","volume":"114","author":"Jauregui","year":"1978","journal-title":"Archives of dermatology"},{"issue":"11","key":"10.1053\/j.semdp.2018.02.001_bib0066","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00277-013-1741-1","article-title":"Reversible iatrogenic, MTX-associated EBV-driven lymphoproliferation with histopathological features of a lymphomatoid granulomatosis in a patient with rheumatoid arthritis","volume":"92","author":"Kobayashi","year":"2013","journal-title":"Ann Hematol"},{"issue":"9","key":"10.1053\/j.semdp.2018.02.001_bib0067","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/DAD.0000000000000198","article-title":"EBV-Negative Cutaneous Lymphomatoid Granulomatosis With Concomitant EBV-Positive Pulmonary Involvement: A Potential Diagnostic and Prognostic Pitfall","volume":"37","author":"Messana","year":"2015","journal-title":"The American Journal of dermatopathology"},{"issue":"22","key":"10.1053\/j.semdp.2018.02.001_bib0068","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1200\/JCO.2012.47.4999","article-title":"Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high-dose cytarabine chemotherapy without stem-cell transplantation","volume":"31","author":"Aoki","year":"2013","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0069","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archderm.1981.01650040012011","article-title":"Cutaneous manifestations of lymphomatoid granulomatosis. Report of 44 cases and a review of the literature","volume":"117","author":"James","year":"1981","journal-title":"Archives of dermatology"},{"issue":"5","key":"10.1053\/j.semdp.2018.02.001_bib0070","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V72.5.1674.1674","article-title":"Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations","volume":"72","author":"Lipford","year":"1988","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0071","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2559.1994.tb01373.x","article-title":"Epstein-Barr virus in cutaneous lymphomatoid granulomatosis","volume":"25","author":"Angel","year":"1994","journal-title":"Histopathology"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0072","first-page":"435","article-title":"Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique","volume":"3","author":"Katzenstein","year":"1990","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1053\/j.semdp.2018.02.001_bib0073","unstructured":"Gaulard P., Jaffe E.S., Krenacs L., Macon W.R.. Hepatosplenic T-cell lymphoma. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017."},{"key":"10.1053\/j.semdp.2018.02.001_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell Lymphoma: A Review of Clinicopathologic Features, Pathogenesis and Prognostic Factors","author":"Yabe","year":"2018","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2018.02.001_bib0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ajh.24791","article-title":"The aggressive peripheral T-cell lymphomas: 2017","volume":"92","author":"Armitage","year":"2017","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0076","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/annrheumdis-2017-211623","article-title":"Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project","volume":"76","author":"Mercer","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0077","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000338144","article-title":"Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented","volume":"30","author":"Beaugerie","year":"2012","journal-title":"Dig Dis"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0078","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4245","article-title":"Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis","volume":"138","author":"Brinkert","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0079","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/MIB.0000000000000245","article-title":"Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease","volume":"21","author":"Cozijnsen","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study","volume":"108","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0081","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcp\/aqw213","article-title":"T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH\/EAHP Workshop Report-Part 4","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0082","first-page":"160","article-title":"Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated Disease","volume":"11","author":"Montgomery","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"12","key":"10.1053\/j.semdp.2018.02.001_bib0083","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.semdp.2018.02.001_bib0084","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2016.10.005","article-title":"Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-alpha inhibitor therapy and literature review","volume":"26","author":"Yabe","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1309\/AJCPVBI47QPVTJOW","article-title":"Hematologic features of hepatosplenic T-cell lymphoma","volume":"137","author":"Erber","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2018.02.001_bib0086","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.3109\/10428194.2014.889821","article-title":"Challenges and new prospects in hepatosplenic gammadelta T-cell lymphoma","volume":"55","author":"Calvaruso","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0087","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1309\/AJCPCOPRE1HGD0FC","article-title":"Differential diagnosis of CD4-\/CD8- gammadelta T-cell large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma","volume":"137","author":"Chen","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2018.02.001_bib0088","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing Between Hepatosplenic T-cell Lymphoma and gammadelta T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"26 Suppl 1","key":"10.1053\/j.semdp.2018.02.001_bib0089","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","article-title":"Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls","author":"Jaffe","year":"2013","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2018.02.001_bib0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2018.02.001_bib0091","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.humpath.2015.11.010","article-title":"Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients","volume":"50","author":"Yabe","year":"2016","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2018.02.001_bib0092","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1309\/PNXUKA1CFJMVGCN1","article-title":"Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization","volume":"130","author":"Feldman","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2018.02.001_bib0093","doi-asserted-by":"crossref","first-page":"e102977","DOI":"10.1371\/journal.pone.0102977","article-title":"Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma","volume":"9","author":"Finalet Ferreiro","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.semdp.2018.02.001_bib0094","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00428-006-0267-5","article-title":"Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration","volume":"449","author":"Tamaska","year":"2006","journal-title":"Virchows Arch"},{"issue":"24","key":"10.1053\/j.semdp.2018.02.001_bib0095","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2018.02.001_bib0096","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder","volume":"15","author":"Luskin","year":"2015","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0097","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00000478-200003000-00006","article-title":"Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity","volume":"24","author":"Nelson","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2018.02.001_bib0098","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.1998.16.6.2052","article-title":"Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity","volume":"16","author":"Leblond","year":"1998","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2018.02.001_bib0099","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ajt.12196","article-title":"Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders","volume":"13","author":"Morscio","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.semdp.2018.02.001_bib0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/PDM.0b013e31804f54a9","article-title":"Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders","volume":"16","author":"Craig","year":"2007","journal-title":"Diagn Mol Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257018300194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257018300194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:12:10Z","timestamp":1660540330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257018300194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0740257018300194"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2018.02.001","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}